second-generation antipsychotic

Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.

By |2024-06-26T12:57:54-04:00March 27th, 2024|Antipsychotic Medications, Child Outcomes, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications, Research at CWMH|Comments Off on Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications

In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.

By |2023-02-06T10:08:37-04:00January 25th, 2023|Antipsychotic Medications, Pregnancy & Medications|Comments Off on Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications

New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

The newer “atypical” or second-generation antipsychotic agents are now used  to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders.  The National Pregnancy Registry for Atypical Antipsychotics [...]

By |2018-10-18T10:27:45-04:00August 24th, 2018|Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

New Research from the CWMH: Gestational Weight Gain in Women Taking Second Generation Antipsychotics During Pregnancy

The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase.  These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders. [...]

By |2020-01-25T23:56:18-04:00November 1st, 2017|Antipsychotic Medications, Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Gestational Weight Gain in Women Taking Second Generation Antipsychotics During Pregnancy

New Research from the CWMH: Newer Antipsychotics and Pregnancy

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-03-28T13:02:50-04:00March 10th, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Newer Antipsychotics and Pregnancy

New Research from the CWMH: Reassuring Data from the National Pregnancy Registry of Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-03-28T13:02:50-04:00October 7th, 2015|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Reassuring Data from the National Pregnancy Registry of Atypical Antipsychotics
Go to Top